Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice - PubMed
- ️Invalid Date
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice
Meena S Madhur et al. Arterioscler Thromb Vasc Biol. 2011 Jul.
Abstract
Objective: Interleukin 17A (IL17A) is involved in many inflammatory processes, but its role in atherosclerosis remains controversial. We examined the role of IL17A in mouse and human atherosclerosis.
Methods and results: Atherosclerosis was induced in apolipoprotein E (ApoE)(-/-) and IL17A/ApoE(-/-) mice using high-fat feeding, angiotensin II infusion, or partial carotid ligation. In ApoE(-/-) mice, 3 months of high-fat diet induced interferon-γ production by splenic lymphocytes, and this was abrogated in IL17A/ApoE(-/-) mice. IL17A/ApoE(-/-) mice had reduced aortic superoxide production, increased aortic nitric oxide levels, decreased aortic leukocyte and dendritic cell infiltration, and reduced weight gain after a high-fat diet compared with ApoE(-/-) mice. Despite these favorable effects, IL17A deficiency did not affect aortic plaque burden after a high-fat diet or angiotensin II infusion. In a partial carotid ligation model, IL17A deficiency did not affect percentage of stenosis but reduced outward remodeling. In this model, neutralization of the related isoform, IL17F, in IL17A/ApoE(-/-) mice did not alter atherosclerosis. Finally, there was no correlation between IL17A levels and carotid intima-media thickness in humans.
Conclusions: IL17 contributes to vascular and systemic inflammation in experimental atherosclerosis but does not alter plaque burden. The changes in plaque composition caused by IL17 might modulate plaque stability.
Figures

Cytokine production, body weight and vascular reactive oxygen species in ApoE−/− and IL17/ApoE−/− mice in response to high fat diet. Splenic lymphocytes from ApoE−/− and IL17/ApoE−/− mice fed regular (Reg) diet or high fat (HF) diet for 3 months were cultured on anti-CD3 plates and the culture supernatants were analyzed for IL17A using ELISA (A), or cytokine bead array (B–D) [n=4–7 per group]. Body weight (in grams) was measured at baseline and after 3 months of HF diet in ApoE−/− and IL17/ApoE−/− mice (panel E, n=12–15 per group). Aortic superoxide production was measured by dihydroethidium-HPLC (panel F, n=5–7 per group). Aortic nitric oxide levels after 3 months of high fat diet feeding were measured by electron spin resonance (ESR). Example ESR spectra are shown in panel G and summary data are shown in panel H [n=4–5 per group]. Data in panels A and H were analyzed using Student's t test. Data in panel E were analyzed using two way repeated measures ANOVA. Other statistical data were analyzed using one way ANOVA with Neuman-Keuls post-hoc test.

ApoE−/− and IL17/ApoE−/− mice were fed a high fat diet for 3 months. Atherosclerotic plaque burden in the descending aortas was quantified using planimetry. Example aortas are shown in panel A and mean values are shown in panel B [n=14–16 per group; p=n.s.]. Atherosclerotic plaque area in the aortic root was analyzed by paraffin sectioning, hematoxylin and eosin staining, and planimetry using ImageJ software. Example sections are shown in panel C, and mean data are shown in panel D [n=7 per group; p=n.s.]. Data were analyzed using Student's t test.

Effect of IL17 on Plaque Composition. ApoE−/− and IL17/ApoE−/− mice were fed 3 months of high fat diet. Panel A shows Russell-Movat pentachrome staining in the aortic root at 4× and 10× magnification. Black=elastic fibers, yellow=collagen, blue/green=mucins, red=muscle, intense red=fibrinoid. Figures are representative of 4 per group. To analyze inflammatory cell content, flow cytometry of single cell suspensions of whole aortas were performed as shown in panel B. Representative scatter plots are shown on the left, and summary data of n=9–12 mice per group are shown on the right. Data were analyzed using Student's t test. CD45+ cells represent total leukocytes, CD3+ cells represent T cells, CD11b-11c+ cells represent dendritic cells, and CD11b+F4/80+ cells represent macrophages. Panel C shows plaque macrophage content in the aortic root as determined by immunostaining with a Mac3 antibody. Alkaline phosphatase (pink) was used to detect the secondary antibody. Slides were counterstained with hematoxylin. A representative of n=3 per group is shown at 4× and 10× magnification.

Effect of IL17 on Angiotensin II Induced Atherosclerosis and Examination of IL17F Levels. ApoE−/− and IL17/ApoE−/− mice were infused with angiotensin II for 4 weeks via osmotic minipump. Atherosclerotic lesions in the thoracic aortas were quantified by planimetry (A). Example aortas are shown on the left, and summary data are shown on the right [n=7 per group; p=n.s.]. Splenic lymphocytes from ApoE−/− and IL17/ApoE−/− mice fed regular (Reg) diet or high fat (HF) diet for 3 months were cultured on anti-CD3 plates, and IL17F released into the media was measured by ELISA [panel B, n=5–7 per group]. Data were analyzed using Student's t test. The statistical values in panel B represent a Bonferonni correction for 4 comparisons.

Effect of IL17A and F Isoforms on Partial Carotid Ligation Induced Atherosclerosis. The left carotid artery (LCA) of ApoE−/− and IL17A/ApoE−/− mice was partially ligated followed by 2 weeks of high fat feeding to induce accelerated atherosclerosis in the ligated artery. Mice were injected weekly with IL17F or isotype control antibody for 3 weeks starting one week before ligation. Frozen sections of carotid arteries were stained with Oil Red O, hematoxylin, and eosin. A representative LCA and right carotid artery (RCA) from each group is shown in (A). Quantification of internal elastic lamina (IEL) area of the LCA is shown in (B), and percent stenosis of the LCA is shown in (C) [n=5 per group]. Data were analyzed using one way ANOVA.
Comment in
-
Interleukin-17 and atherosclerotic vascular disease.
Pober JS. Pober JS. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1465-6. doi: 10.1161/ATVBAHA.111.228338. Arterioscler Thromb Vasc Biol. 2011. PMID: 21677287 No abstract available.
Similar articles
-
Shami A, Gustafsson R, Kalamajski S, Krams R, Segers D, Rauch U, Roos G, Nilsson J, Oldberg Å, Hultgårdh-Nilsson A. Shami A, et al. Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):354-61. doi: 10.1161/ATVBAHA.112.300723. Epub 2012 Nov 29. Arterioscler Thromb Vasc Biol. 2013. PMID: 23202368
-
Butcher MJ, Waseem TC, Galkina EV. Butcher MJ, et al. Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1496-506. doi: 10.1161/ATVBAHA.116.307892. Epub 2016 Jun 30. Arterioscler Thromb Vasc Biol. 2016. PMID: 27365405 Free PMC article.
-
Macritchie N, Grassia G, Sabir SR, Maddaluno M, Welsh P, Sattar N, Ialenti A, Kurowska-Stolarska M, McInnes IB, Brewer JM, Garside P, Maffia P. Macritchie N, et al. Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2569-79. doi: 10.1161/ATVBAHA.112.251314. Epub 2012 Aug 30. Arterioscler Thromb Vasc Biol. 2012. PMID: 22936340
-
Current views on the functions of interleukin-17A-producing cells in atherosclerosis.
Butcher M, Galkina E. Butcher M, et al. Thromb Haemost. 2011 Nov;106(5):787-95. doi: 10.1160/TH11-05-0342. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21946932 Free PMC article. Review.
-
Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse.
Vasquez EC, Peotta VA, Gava AL, Pereira TM, Meyrelles SS. Vasquez EC, et al. J Biomed Sci. 2012 Feb 13;19(1):22. doi: 10.1186/1423-0127-19-22. J Biomed Sci. 2012. PMID: 22330242 Free PMC article. Review.
Cited by
-
Kang L, Hillestad ML, Grande JP, Croatt AJ, Barry MA, Farrugia G, Katusic ZS, Nath KA. Kang L, et al. Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1402-13. doi: 10.1152/ajpheart.00882.2014. Epub 2015 Mar 27. Am J Physiol Heart Circ Physiol. 2015. PMID: 25820397 Free PMC article.
-
Conflicting mechanisms of AT2 cardioprotection revealed.
Altara R, Didion SP, Booz GW. Altara R, et al. Cardiovasc Res. 2016 Oct;112(1):426-8. doi: 10.1093/cvr/cvw199. Cardiovasc Res. 2016. PMID: 27659501 Free PMC article. No abstract available.
-
Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction.
Karbach SH, Schönfelder T, Brandão I, Wilms E, Hörmann N, Jäckel S, Schüler R, Finger S, Knorr M, Lagrange J, Brandt M, Waisman A, Kossmann S, Schäfer K, Münzel T, Reinhardt C, Wenzel P. Karbach SH, et al. J Am Heart Assoc. 2016 Aug 30;5(9):e003698. doi: 10.1161/JAHA.116.003698. J Am Heart Assoc. 2016. PMID: 27577581 Free PMC article.
-
Stabilization of high-risk plaques.
Takata K, Imaizumi S, Zhang B, Miura S, Saku K. Takata K, et al. Cardiovasc Diagn Ther. 2016 Aug;6(4):304-21. doi: 10.21037/cdt.2015.10.03. Cardiovasc Diagn Ther. 2016. PMID: 27500090 Free PMC article. Review.
-
The immune system and hypertension.
Singh MV, Chapleau MW, Harwani SC, Abboud FM. Singh MV, et al. Immunol Res. 2014 Aug;59(1-3):243-53. doi: 10.1007/s12026-014-8548-6. Immunol Res. 2014. PMID: 24847766 Free PMC article. Review.
References
-
- Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–1132. - PubMed
-
- Taleb S, Tedgui A, Mallat Z. Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol. 2010;10:197–202. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL039006/HL/NHLBI NIH HHS/United States
- F32 HL092738/HL/NHLBI NIH HHS/United States
- P01-HL58000/HL/NHLBI NIH HHS/United States
- TL1 RR025010/RR/NCRR NIH HHS/United States
- P01 HL058000/HL/NHLBI NIH HHS/United States
- TL1 TR000456/TR/NCATS NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- R01 HL039006-23/HL/NHLBI NIH HHS/United States
- P01 HL058000-10/HL/NHLBI NIH HHS/United States
- UL1 RR025008/RR/NCRR NIH HHS/United States
- F32 HL092738-01/HL/NHLBI NIH HHS/United States
- R01-HL39006/HL/NHLBI NIH HHS/United States
- P01 HL058000-11A1/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous